← Open Payments lookup

CHRISTINE KARELL: Open Payments

NPI 1053480590 · ALLIANCE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$899 in 43 payments from 10 companies in 2025. Trend: 2023 $759 · 2024 $546 · 2025 $899

Food & beverage: $828Education: $71
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.14$261
ABBVIE INC.6$157
Otsuka America Pharmaceutical, Inc.7$142
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$141
Alkermes, Inc.4$70
Lilly USA, LLC2$46
Axsome Therapeutics, Inc.2$32
Collegium Pharmaceutical, Inc.1$20
E.R. Squibb & Sons, L.L.C.1$17
Supernus Pharmaceuticals, Inc.1$14

Products named: VRAYLAR, UZEDY, CAPLYTA, ABILIFY MAINTENA, ARISTADA, REXULTI, AUSTEDO XR, Auvelity.

Industry payments across NE — which companies pay providers there.